- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Statement
In large clinical trials conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With...
Showing 7 out of 1847 results
Research Feature
The $63 million NHLBI Large-Scale DNA Sequencing Project is a "Grand Opportunity" Recovery Act project that will find genetic signatures for heart, lung, and blood diseases that account for 3 of the 4 leading causes of death in the United States. President Barack Obama announced the award September 30, 2009, as part of the $5 billion in new...
NHLBI in the Press
Researchers are reporting a new way of analyzing genetic test data that may help identify people at high risk of heart disease and other common medical conditions.
Research Feature
The National Heart, Lung, and Blood Institute’s Division of Blood Diseases and Resources (DBDR) has reorganized its structure to reflect the research pathway — from laboratory investigations to clinical trials to real-world implementation studies, and back to basic investigations, with the various translational steps in between these areas....
Research Feature
A long-term study of children with a potentially life-threatening heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate heart transplantation was greatest for those who developed certain subtypes of this disease as infants with congestive heart failure and for children who also had inborn errors...
Research Feature
National Institutes of Health- (NIH) supported research is shedding light on how sleep and lack of sleep affect the human body. The NIH and its partners will continue to work together to advance sleep research. Download an accessible PDF version of the infographic .